Corrigendum to "Pharmacogenetics of Risperidone and Cardiovascular Risk in Children and Adolescents"
Int J Endocrinol
.
2017:2017:8165368.
doi: 10.1155/2017/8165368.
Epub 2017 May 3.
Authors
Amilton Dos Santos-Júnior
1
,
Taciane Barbosa Henriques
2
,
Maricilda Palandi de Mello
2
,
Osmar Henrique Della Torre
1
,
Lúcia Arisaka Paes
1
,
Adriana Perez Ferreira-Neto
1
,
Letícia Esposito Sewaybricker
3
,
Thiago Salum Fontana
1
,
Eloisa Helena Rubello Valler Celeri
1
,
Gil Guerra-Júnior
3
4
,
Paulo Dalgalarrondo
1
Affiliations
1
Department of Psychiatry, School of Medical Sciences (FCM), State University of Campinas (Unicamp), 13083-887 Campinas, SP, Brazil.
2
Laboratory of Human Genetics, Center for Molecular Biology and Genetic Engineering (CBMEG), Unicamp, 13083-875 Campinas, SP, Brazil.
3
Growth and Development Laboratory, Center for Investigation in Pediatrics (CIPED), FCM-Unicamp, 13083-887 Campinas, SP, Brazil.
4
Department of Pediatrics, Pediatric Endocrinology Unit, FCM-Unicamp, 13083-887 Campinas, SP, Brazil.
PMID:
28592969
PMCID:
PMC5448052
DOI:
10.1155/2017/8165368
Abstract
[This corrects the article DOI: 10.1155/2016/5872423.].
Publication types
Published Erratum